Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong-Ke Liu

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
European Journal of Medicinal Chemistry|December 6, 2021
Biotinylated curcumin as a novel chemosensitizer enhances naphthalimide-induced autophagic cell death in breast cancer cellsChenwen Shao, Jian Wu, Siqi Han, et al.
Journal of Inorganic Biochemistry|July 29, 2022
The cyclometalated iridium (III) complex based on 9-Anthracenecarboxylic acid as a lysosomal-targeted anticancer agentLu Liu, Jun Chen, Meng-Meng Wang, et al.
Journal of Inorganic Biochemistry|April 27, 2024
Mitochondria-targeted ruthenium complexes can be generated in vitro and in living cells to target triple-negative breast cancer cells by autophagy inhibitionGuan-Dong Zhang, Meng-Meng Wang, Yan Su, et al.
Journal of Inorganic Biochemistry|November 18, 2023
Cyclometalated iridium(III) complexes as anti-breast cancer and anti-metastasis agents via STAT3 inhibitionYan Su, Jin Yang, Meng-Meng Wang, et al.
Dalton Transactions (Cambridge, England : 2003)|February 5, 2015
Binding of an organo-osmium(II) anticancer complex to guanine and cytosine on DNA revealed by electron-based dissociations in high resolution Top-Down FT-ICR mass spectrometryChristopher A Wootton, Carlos Sanchez-Cano, Hong-Ke Liu, et al.
Chemical Science|February 28, 2022
Fighting metallodrug resistance through alteration of drug metabolism and blockage of autophagic flux by mitochondria-targeting AIEgensYan Su, Hai Lin, Ying Tu, et al.
Dalton Transactions (Cambridge, England : 2003)|May 19, 2012
Two solvent and temperature dependent copper(II) compounds formed by a flexible ligand: syntheses, structures and SC-SC transformationHaixia Sun, Wenli Xie, Shenghong Lv, et al.
Journal of Inorganic Biochemistry|December 27, 2025
Cyclometalated iridium complex as a PD-L1 inhibitor: Suppressing expression via COX-2 blockadeYating Zhang, Jingyue Zhao, Zhengqi Shen, et al.
Journal of Inorganic Biochemistry|November 5, 2021
Mitochondria-targeted Pt(IV) prodrugs conjugated with an aggregation-induced emission luminogen against breast cancer cells by dual modulation of apoptosis and autophagy inhibitionYan Su, Ying Tu, Hai Lin, et al.
Journal of Inorganic Biochemistry|November 12, 2022
Unlocking the potential of iridium and ruthenium arene complexes as anti-tumor and anti-metastasis chemotherapeutic agentsMengdi Lv, Xiaoting Qian, Shijie Li, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
European Journal of Medicinal Chemistry|December 6, 2021
Biotinylated curcumin as a novel chemosensitizer enhances naphthalimide-induced autophagic cell death in breast cancer cellsChenwen Shao, Jian Wu, Siqi Han, et al.
Journal of Inorganic Biochemistry|July 29, 2022
The cyclometalated iridium (III) complex based on 9-Anthracenecarboxylic acid as a lysosomal-targeted anticancer agentLu Liu, Jun Chen, Meng-Meng Wang, et al.
Journal of Inorganic Biochemistry|April 27, 2024
Mitochondria-targeted ruthenium complexes can be generated in vitro and in living cells to target triple-negative breast cancer cells by autophagy inhibitionGuan-Dong Zhang, Meng-Meng Wang, Yan Su, et al.
Journal of Inorganic Biochemistry|November 18, 2023
Cyclometalated iridium(III) complexes as anti-breast cancer and anti-metastasis agents via STAT3 inhibitionYan Su, Jin Yang, Meng-Meng Wang, et al.
Dalton Transactions (Cambridge, England : 2003)|February 5, 2015
Binding of an organo-osmium(II) anticancer complex to guanine and cytosine on DNA revealed by electron-based dissociations in high resolution Top-Down FT-ICR mass spectrometryChristopher A Wootton, Carlos Sanchez-Cano, Hong-Ke Liu, et al.
Chemical Science|February 28, 2022
Fighting metallodrug resistance through alteration of drug metabolism and blockage of autophagic flux by mitochondria-targeting AIEgensYan Su, Hai Lin, Ying Tu, et al.
Dalton Transactions (Cambridge, England : 2003)|May 19, 2012
Two solvent and temperature dependent copper(II) compounds formed by a flexible ligand: syntheses, structures and SC-SC transformationHaixia Sun, Wenli Xie, Shenghong Lv, et al.
Journal of Inorganic Biochemistry|December 27, 2025
Cyclometalated iridium complex as a PD-L1 inhibitor: Suppressing expression via COX-2 blockadeYating Zhang, Jingyue Zhao, Zhengqi Shen, et al.
Journal of Inorganic Biochemistry|November 5, 2021
Mitochondria-targeted Pt(IV) prodrugs conjugated with an aggregation-induced emission luminogen against breast cancer cells by dual modulation of apoptosis and autophagy inhibitionYan Su, Ying Tu, Hai Lin, et al.
Journal of Inorganic Biochemistry|November 12, 2022
Unlocking the potential of iridium and ruthenium arene complexes as anti-tumor and anti-metastasis chemotherapeutic agentsMengdi Lv, Xiaoting Qian, Shijie Li, et al.
Pageof 6